Skip to main content
. 2014 Mar 21;20(11):2854–2866. doi: 10.3748/wjg.v20.i11.2854

Table 1.

Major advantages and limitations of liver biopsy and noninvasive fibrosis markers

Liver biopsy Noninvasive markers
Advantages
Validated scoring systems Absence of significant discomfort and risks
Differential diagnosis and associated conditions Allows frequent re-evaluation
Simultaneous evaluation of necro-inflammation Objective interpretation
Patient acceptance
Limitations
Invasive Low accuracy to discriminate between intermediate stages of fibrosis
High cost Nonspecific for the liver (biomarkers)
Sampling errors and intra- and inter-observer variability Influence of several extra-hepatic factors